Compare Prudential Financial Inc (PRU) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Prudential Financial Inc vs ResMed Inc. — how do they compare? Prudential Financial Inc trades at $118.18 (market cap $40.97B), while ResMed Inc. trades at $193.21 (market cap $28.40B). The key difference: Prudential Financial Inc is the larger of the two by market cap, and Prudential Financial Inc pays the higher dividend (4.75%). Which is the better fit depends on your goals.
| PRU | RMD | |
|---|---|---|
Market Cap | $40.97B | $28.40B |
Sector | Financials | Health |
52-Week High | $119.07 | $293.73 |
52-Week Low | $92.00 | $182.82 |
Enterprise Value | $68.03B | $27.58B |
Dividend Yield | 4.75% | 1.23% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Prudential Financial Inc
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
